During the working session, Mayda Mauri Pérez, President of BioCubaFarma, showcased the group’s key pharmaceutical products, including Heberprot-P for diabetic foot ulcer treatment, Hebermin for ...
Department of Physiology, State Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Basic Medical Sciences and School of Basic Medicine, ...
An EGFR gene mutation is one of the biomarkers a doctor often tests for after confirming a diagnosis of non-small cell lung cancer (NSCLC). Biomarkers can help guide treatment. EGFR mutations ...
Initiatives to engineer therapies targeting these dysregulated pathways are underway, with several candidate molecules progressing to clinical evaluation phases, including FDA approval for agents like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback